FMR LLC - ONCOCYTE CORP ownership

ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 2 filers reported holding ONCOCYTE CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
FMR LLC ownership history of ONCOCYTE CORP
ValueSharesWeighting
Q2 2023$2
-75.0%
10
-50.0%
0.00%
Q1 2023$8
+166.7%
20
+100.0%
0.00%
Q4 2022$3
-100.0%
10
-99.8%
0.00%
Q2 2022$6,000
+50.0%
6,078
+128.8%
0.00%
Q1 2022$4,0002,6570.00%
Other shareholders
ONCOCYTE CORP shareholders Q3 2023
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 17,349,945$61,766,0003.15%
Defender Capital, LLC. 1,960,820$6,935,0002.26%
Millrace Asset Group, Inc. 613,885$2,185,0001.36%
PURA VIDA INVESTMENTS, LLC 12,223,953$43,517,0001.32%
Penbrook Management LLC 577,200$2,055,0001.28%
ACT CAPITAL MANAGEMENT, LLC 330,000$1,175,0000.61%
AWM Investment Company, Inc. 717,000$2,553,0000.25%
Colonial River Wealth Management, LLC 66,200$218,0000.15%
CALIBER WEALTH MANAGEMENT, LLC 66,200$218,0000.15%
Fort Sheridan Advisors LLC 110,000$392,0000.13%
View complete list of ONCOCYTE CORP shareholders